Clinical Trials & Research
Search Clinical Trials
Clinical Trials
New Search
Title | A PHASE 3, PLACEBO CONTROLLED, DOUBLE-BLIND, RANDOMIZED, CLINICAL STUDY TO DETERMINE EFFICACY, SAFETY AND TOLERABILITY OF PULSED, INHALED NITRIC OXIDE (iNO) VERSUS PLACEBO IN SYMPTOMATIC SUBJECTS WITH PULMONARY ARTERIAL HYPERTENSION (PAH) INOvation-1 |
---|---|
Full Title | A PHASE 3, PLACEBO CONTROLLED, DOUBLE-BLIND, RANDOMIZED, CLINICAL STUDY TO DETERMINE EFFICACY, SAFETY AND TOLERABILITY OF PULSED, INHALED NITRIC OXIDE (iNO) VERSUS PLACEBO IN SYMPTOMATIC SUBJECTS WITH PULMONARY ARTERIAL HYPERTENSION (PAH) INOvation-1 |
Disease/Condition | Cardiology |
Description | |
Eligibility Criteria | Click here for eligibility requirements |
Principal Investigator | Ali Zaidi |
Contact Name | Wolfgang Jorde |
Contact Email | wjorde@montefiore.org |
Protocol Number | IRB# 16-02-168-01 |
Inclusion/Notes | This information was obtained from ClinicalTrials.gov. |
Status | Enrolling |
Adult Clinical Trial | No |
Pediatric Clinical Trial | No |